Anaplastic Oligodendroglioma

general

A WHO grade 3 oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).

28

Centers

21

Active Trials

$2M

Cancer Funding

Top Centers for Anaplastic Oligodendroglioma(28)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
74.3
2
NCI Comprehensive
Active Research Program
68.8
3
NCI Clinical
Active Research Program
68.8
4
Active Research Program
68.8
5
Active Research Program
68.8
6
Active Research Program
68.8
7
Active Research Program
68.8
8
NCI Comprehensive
Active Research Program
56.8
9
NCI Comprehensive
Active Research Program
56.8
10
NCI Comprehensive
Active Research Program
56.8
11
NCI Comprehensive
Active Research Program
56.8
12
Active Research Program
56.8
13
NCI Clinical
Active Research Program
56.8
14
Active Research Program
56.8
15
BC CancerVancouver, BC
Active Research Program
56.8
1639.1
17
NCI Comprehensive
39.1
18
NCI Comprehensive
39.1
19
NCI Comprehensive
39.1
20
NCI Comprehensive
39.1
21
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
39.1
22
NCI Comprehensive
39.1
23
NCI Comprehensive
39.1
2439.1
25
NCI Comprehensive
39.1
26
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
39.1
2739.1
2839.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →